Sign in

CIK 0001167419

  • Large accelerated filer

Riot Platforms, Inc.

Sign in to watch
Ticker
RIOT
Exchange
Nasdaq
Industry
Finance Services
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
841553387
Phone
+1 303-794-2000
Business address
85 RIO GRANDE DRIVE, SUITE 200, CASTLE ROCK, CO, 80104
Former names
Riot Blockchain, Inc., Bioptix, Inc., Venaxis, Inc., AspenBio Pharma, Inc., ASPENBIO INC
  1. 4 Planned sale CEO sold 100,000 shares at $15.12 ($1,512,000)
  2. 4 Grant or award Director acquired 16,103 shares (grant or award)
  3. 4 Grant or award Director acquired 16,103 shares (grant or award)
  4. 4 Grant or award Director acquired 16,103 shares (grant or award)
  5. 4 Grant or award Director acquired 16,103 shares (grant or award)
  6. 4/A Planned sale SVP, CAO sold 3,747 shares at $11.88 ($44,514)
  7. 4 Open-market sale SVP, CAO sold 3,747 shares at $11.88 ($44,514)
  8. 4 Shares withheld for taxes SVP, CAO gave up 12,965 shares (to pay taxes)
  9. 4 Shares withheld for taxes COO gave up 20,345 shares (to pay taxes)
  10. 4 Shares withheld for taxes CEO gave up 101,610 shares (to pay taxes)
  11. 4 Option exercise EVP, CFO acquired 124,823 shares (option exercise)
  12. 4 Option exercise Director acquired 12,000 shares (option exercise)
  13. 4 Grant or award CDCO acquired 583,430 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 8,384 shares at $7.74 ($64,892)
  16. 4 Open-market sale Director sold 12,000 shares at $7.70 ($92,400)
  17. 4 Open-market sale Director sold 61,000 shares at $9.58 ($584,380)
  18. 4 Grant or award Director acquired 12,000 shares (grant or award)
  19. 4 Grant or award Director acquired 12,000 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 3 of 30 · 598 filings